Antimicrobial+Drugs powerpoint

Focus on understanding various aspects of antimicrobial drugs and their impact on health.

Paul Ehrlich (early 1900s): Pioneered the idea of a "magic bullet" for targeted pathogen destruction (chemotherapy), emphasizing the need for drugs that could selectively target pathogens without harming the host.
1928: Discovery of penicillin by Alexander Fleming, derived from Penicillium mold, which marked the beginning of antibiotic therapy and revolutionized modern medicine by effectively treating bacterial infections.
1940: Clinical trials of penicillin conducted by Howard Florey and Ernst Chain verified its efficacy, leading to mass production during World War II and saving countless lives.

Chemotherapy: Use of chemicals (drugs) for disease treatment, particularly those that target living organisms.
Chemotherapeutic Agent: Any drug used to treat diseases, including those with antimicrobial properties.
Antimicrobial Agent: Chemical used against infectious diseases, encompassing a broad range of substances including antibiotics, antifungals, antivirals, and antiparasitics.
Antibiotic: Substances from microorganisms that kill or inhibit other microorganisms, specifically bacteria.
Types of Antibiotics:
- Natural Antibiotics: Isolated from organisms, such as penicillin from mold.
- Semisynthetic Antibiotics: Derived from natural sources but chemically altered to enhance effectiveness or spectrum, e.g., amoxicillin.
- Synthetic Antibiotics: Lab-created drugs, such as sulfonamides, that are designed to have specific antimicrobial properties.

Cellular Processes Targeted: Antimicrobial drugs disrupt essential cellular processes in pathogens, such as cell wall synthesis, protein synthesis, and DNA replication.
Selective Toxicity: A crucial principle; drugs must selectively target pathogens without harming human cells.

Inhibition of Cell Wall Synthesis: Weakens bacterial walls leading to lysis, effective against actively dividing bacteria.
Damage to Cell Membranes: Compromises structural integrity, causing cell death; often used against both gram-positive and gram-negative bacteria.
Inhibition of Nucleic Acid Synthesis: Prevents DNA/RNA replication and transcription, crucial for bacterial reproduction.
Inhibition of Protein Synthesis: Blocks translation at the ribosomes, halting protein production, leading to cell death or stasis.
Inhibition of Enzyme Activity: Disrupts critical metabolic activities essential for microbial growth.

Beta-Lactams: Includes penicillins, cephalosporins, and glycopeptides, effective primarily against bacteria.
Nucleic Acid Synthesis Inhibitors: Fluoroquinolones and Rifamycins; targeting DNA replication processes.
Protein Synthesis Inhibitors: Include aminoglycosides, tetracyclines, and macrolides, impacting bacterial ribosomal function.
Metabolic Pathway Inhibitors: Sulfonamides and trimethoprim; targeting bacterial metabolic pathways.

β-Lactamases: Enzymes that deactivate β-lactam antibiotics (e.g., penicillinases), posing a significant challenge in treating bacterial infections.
Mechanisms of Resistance:
- Enzymatic Destruction: Enzymes inactivate drugs, effectively neutralizing their action.
- Blocking Entry: Modifications in membrane proteins prevent drug entry.
- Target Site Modification: Changes in binding sites reduce drug efficacy, often necessitating higher doses or alternative therapies.
- Efflux Pumps: Actively remove drugs from bacterial cells, reducing intracellular drug concentration.

Misuse contributes to resistance development through:
- Patient noncompliance (not completing prescribed courses).
- Inappropriate prescriptions (using antibiotics for viral infections).
- Overuse in agriculture (prophylactic use in livestock).
Consequences: Development of superbugs, such as MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus), which are much more difficult to treat.

Kirby-Bauer Disk Diffusion: Tests effectiveness via inhibition zones, allowing the determination of sensitivity and resistance profiles.
Minimum Inhibitory Concentration (MIC): Lowest concentration preventing growth, essential for determining effective dosages.
Empiric Therapy: Treatment initiated before lab results based on educated guesses, requiring clinician experience.

Selective Toxicity: Aim for a high therapeutic index (safe vs effective), essential for patient safety.
Broad-spectrum vs Narrow-spectrum: Uses depend on targeted microorganisms; broad-spectrum targets a wide range, while narrow-spectrum is more focused.
Synergism vs Antagonism: Combined effects can lead to more effective treatment or undesired outcomes (antagonism hampers effectiveness).